Sarcopenia and Intervention Physical Therapy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Neuromuscular Electrical Stimulation (NMES) Group,Resistance + BFR Group.
- Who it may be relevant to
- Registry conditions: Sarcopenia. Basic parameters: 60 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effectiveness of Neuromuscular Electrical Stimulation Versus Low-load Resistance Training With Blood Flow Restriction in Elderly Individuals With Sarcopenia
Overview
To evaluate and compare the effectiveness of neuromuscular electrical stimulation (NMES) and low-load resistance training with blood flow restriction (BFR) in improving muscle mass, strength, functional performance, and quality of life in elderly individuals diagnosed with sarcopenia
Detailed description
Sarcopenia, the age-related decline in muscle mass, strength, and function, significantly affects the health and independence of elderly individuals. It increases the risk of frailty, falls, and disability. Neuromuscular electrical stimulation (NMES) and low-load resistance training with blood flow restriction (BFR) are promising rehabilitation strategies for older adults with limited physical capacity. This study aims to compare the effectiveness of NMES and BFR in managing sarcopenia and improving physical and functional outcomes in the elderly
Interventions
- Device Neuromuscular Electrical Stimulation (NMES) Group,Resistance + BFR Group
NMES Group: Receives neuromuscular electrical stimulation to the thigh muscles for 30 minutes, three times per week, over 8 weeks. Resistance + BFR Group: Performs low-load resistance exercises with blood flow restriction applied to the thighs, also for 30 minutes per session, three times per week, over 8 weeks. Control Group: Receives placebo treatment using a turned-off stimulation device with no active intervention during the 8-week period.
Primary outcome measures
- Change in Muscle Mass [Time frame: 2 month]
Secondary outcome measures (2)
- Muscle Strength Handheld dynamometer (e.g., MicroFET) [Time frame: 2 month]
- Timed Up and Go (TUG) Test [Time frame: 2 month]
Eligibility criteria
Inclusion criteria
- Older age (≥ 60-75 years)
Low muscle strength (e.g., low handgrip strength)
Low muscle mass (e.g., ASM/height² below cutoff)
Exclusion criteria
- heart disese
- kidny disese
- autoimune disese
- cognetive disorder
- sever form of sarcopenia
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07013604 · sarcopenia